Diabetes technology

The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system

Diabetes Obes MetabPublished Retrospective cohort study

Authors' conclusion

For MM780G users, CV is a poor marker for hypoglycaemia risk and glycaemic control. We recommend using, for the former, TBR and whether the TBR target is met (and not using CV <36% as a therapeutic threshold for hypoglycaemia); for the latter, TIR, time above range, whether targets are met and a discrete description of mean SG and SD of SG values.

Study context

Population
Real-world users of the MiniMed 780G AID system (MM780G)MM780G users
Participants
10,404 users
Exposure
Coefficient of variation (CV) vs SD and low blood glucose index as markers of hypoglycaemia risk and glycaemic control
Outcome
Contribution of CV to hypoglycaemia risk (not reaching time below range (TBR) target <1%) and to achieving TIR >70% and GMI <7%
Methodological detailsreal-world data, multivariable logistic regression
  • Real-world data
  • Multivariable logistic regression

Main finding

As reported in the abstract

Contribution of CV to hypoglycaemia risk and glycaemic targets
  • Contribution of CV was the smallest for hypoglycaemia risk (vs low blood glucose index and SD) and for TIR and GMI targets (vs SD)
  • Models with SD showed the best fit in all cases

Observational data: associations, not effects.

Further findings

Optimal CV cut-off discriminating users at risk of hypoglycaemia

Optimal cut-off: CV <
43.4% (95% CI 42.9-43.9)
Correct classification rate, CV <43.4%
87.2%
Correct classification rate, CV <36%
72.9%

Original publication

The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system. Diabetes Obes Metab. Published 29 May 2023. doi:10.1111/dom.15139

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.